Cerulean Pharma reported $0 in Loan Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Adamis Pharmaceuticals ADMP:US 0 0
Agile Therapeutics AGRX:US $ 0M 0M
Arrowhead Research ARWR:US $ 0 0
Bayer BAYN:GR € 36648M 167M
Biocept BIOC:US $ 1.22M 0.21M
Brainstorm Cell Therapeutics BCLI:US $ 0M 0M
Cerulean Pharma CERU:US $ 0 0
Immunogen IMGN:US $ 0M 0M
Johnson & Johnson JNJ:US $ 28851M 1134M
Macrogenics MGNX:US $ 0 0
Merk MRK:US $ 30586M 104M
Nektar Therapeutics NKTR:US $ 0M 0M
Perrigo Ordinary Shares PRGO:US $ 3510.6M 593.9M
Pfizer PFE:US $ 35656M 539M
Seattle Genetics SGEN:US $ 0M 0M
YTE INCY:US $ 31.38M 0.25M